Onkure Therapeutics, Inc. · NASDAQ:OKUR
Saccomano Nicholas A sold 87 Onkure Therapeutics, Inc. shares (Form 4)
Traded Sep 21, 2026 · Filed Sep 23, 2026
On Sep 21, 2026, Saccomano Nicholas A (Director, President and CEO) sold 87 Onkure Therapeutics, Inc. shares at US$2.97 for US$258, leaving 11,160 shares. Filed Sep 23, 2026 (Form 4).
- Sold
- 87 shares
- Price
- US$2.97
- Value
- US$258
- Holding after
- 11,160 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Class A Common Stock | Sale | 87 | US$2.97 | 11,160 | Direct |
Source
Related
- Onkure Therapeutics, Inc.
- Saccomano Nicholas A
- Onkure Therapeutics, Inc. shareholders
- Form 4 · Saccomano Nicholas A · Jun 24, 2026
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · Aug 14, 2026
- Schedule 13G/A · Prosight Management, LP · Aug 10, 2026